Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CRANSTON, Aaron")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse modelsCRANSTON, Aaron N; PONDER, Bruce A. J.Cancer research (Baltimore). 2003, Vol 63, Num 16, pp 4777-4780, issn 0008-5472, 4 p.Article

Quantitative phenotyping as an efficient means to estimate C-cell number in a knock-in mouse model of MEN2BCRANSTON, Aaron; HOWARD, Louise; HOWARD, C. Vyvyan et al.Transgenic research. 2004, Vol 13, Num 4, pp 339-348, issn 0962-8819, 10 p.Article

C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RETREYNOLDS, Lucinda; JONES, Ken; WINTON, Douglas J et al.Oncogene (Basingstoke). 2001, Vol 20, Num 30, pp 3986-3994, issn 0950-9232Article

Poly(ADP-Ribose) Polymerase-1 Inhibitor Treatment Regresses Autochthonous Brca2/p53-Mutant Mammary Tumors In vivo and Delays Tumor Relapse in Combination with CarboplatinHAY, Trevor; MATTHEW, James R; CLARKE, Alan R et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 9, pp 3850-3855, issn 0008-5472, 6 p.Article

4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one : A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1MENEAR, Keith A; ADCOCK, Claire; JAVAID, Hashim et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 20, pp 6581-6591, issn 0022-2623, 11 p.Article

Tumor Growth Inhibition by Olaparib in BRCA2 Germline-Mutated Patient-Derived Ovarian Cancer Tissue XenograftsKORTMANN, Ursula; MCALPINE, Jessica N; HUNTSMAN, David G et al.Clinical cancer research (Print). 2011, Vol 17, Num 4, pp 783-791, issn 1078-0432, 9 p.Article

Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injectionBÖCKMANN, Miriam; HILKEN, Gero; SCHMIDT, Anke et al.Human gene therapy. 2005, Vol 16, Num 11, pp 1267-1275, issn 1043-0342, 9 p.Article

Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinomaDROSTEN, Matthias; HILKEN, Gero; BÖCKMANN, Miriam et al.Journal of the National Cancer Institute. 2004, Vol 96, Num 16, pp 1231-1239, issn 0027-8874, 9 p.Article

The retC620R mutation affects renal and enteric development in a mouse model of Hirschsprung's diseaseCARNITI, Cristiana; BELLUCO, Sara; RICCARDI, Elena et al.The American journal of pathology. 2006, Vol 168, Num 4, pp 1262-1275, issn 0002-9440, 14 p.Article

RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2BCRANSTON, Aaron N; CARNITI, Cristiana; PIERONI, Marco A et al.Cancer research (Baltimore). 2006, Vol 66, Num 20, pp 10179-10187, issn 0008-5472, 9 p.Article

Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors1RUSSELL, S. E; MCILHATTON, Michael A; KEILTY, Gillian W et al.Cancer research (Baltimore). 2000, Vol 60, Num 17, pp 4729-4734, issn 0008-5472Article

  • Page / 1